Foghorn Therapeutics, Inc. (FHTX)
4.37
-0.07
(-1.58%)
USD |
NASDAQ |
Dec 15, 14:55
Foghorn Therapeutics Total Liabilities (Quarterly): 294.62M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| GT Biopharma, Inc. | 1.321M |
| Recursion Pharmaceuticals, Inc. | 352.58M |
| Erasca, Inc. | 72.52M |
| OmniAb, Inc. | 32.25M |
| CEL-SCI Corp. | 13.31M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 204.96M |
| Shareholders Equity (Quarterly) | -89.66M |
| Debt to Equity Ratio | -0.2513 |
| Current Ratio | 2.164 |
| Net Debt Paydown Yield | 1.33% |